nifedipine has been researched along with fluorescein-5-isothiocyanate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McDonagh, PF; Roberts, DJ | 1 |
McDonagh, PF; Niven, AT; Roberts, D | 1 |
DurĂ¡n, WN; Hobson, RW; Kim, D; Kobayashi, I; Oshiro, H; Takenaka, H | 1 |
Bouskela, E; Conde, CM; Cyrino, FZ; Garcia, AA | 1 |
4 other study(ies) available for nifedipine and fluorescein-5-isothiocyanate
Article | Year |
---|---|
Prevention of transcoronary macromolecular leakage after ischemia-reperfusion by the calcium entry blocker nisoldipine. Direct observations in isolated rat hearts.
Topics: Animals; Capillaries; Coronary Circulation; Coronary Disease; Coronary Vessels; Extravasation of Diagnostic and Therapeutic Materials; Fluorescein-5-isothiocyanate; Fluoresceins; Nifedipine; Nisoldipine; Nitroglycerin; Perfusion; Rats; Serum Albumin, Bovine; Thiocyanates; Vascular Resistance; Vasodilation | 1986 |
Direct visualization of the coronary microcirculation for pharmacologic and physiologic studies.
Topics: Animals; Calcium Channel Blockers; Capillary Permeability; Capillary Resistance; Coronary Circulation; Fluorescein-5-isothiocyanate; Fluoresceins; Heart Arrest, Induced; Histamine; Male; Microcirculation; Microscopy, Fluorescence; Nifedipine; Nisoldipine; Perfusion; Rats; Rats, Inbred Strains; Serum Albumin, Bovine | 1984 |
L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo.
Topics: Animals; Calcium Channel Blockers; Capillary Permeability; Cricetinae; Dextrans; Fluorescein-5-isothiocyanate; Male; Mesocricetus; Nifedipine; Platelet Activating Factor; Spectrometry, Fluorescence; Vasoconstriction; Verapamil | 1995 |
Microvascular permeability with sulfonylureas in normal and diabetic hamsters.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Capillary Permeability; Cricetinae; Dextrans; Diabetes Mellitus, Experimental; Diazoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Gliclazide; Glyburide; Histamine; Hypoglycemic Agents; Insulin; Macromolecular Substances; Male; Mesocricetus; Nifedipine; Potassium Channels; Reperfusion Injury; Streptozocin; Sulfonylurea Compounds | 1997 |